|
MedChemExpress
blot primary antibodies against ccnd2 Blot Primary Antibodies Against Ccnd2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyclin+d2/Cyclin+D2%2FCCND2+Antibody/10__21203_slash_rs__3__rs___10250209_slash_v1-97-2-24 Average 94 stars, based on 1 article reviews
blot primary antibodies against ccnd2 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Proteintech
cyclin d2 ![]() Cyclin D2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyclin+d2/Cyclin+D2+Antibody/pmc13760668-82-44-50 Average 94 stars, based on 1 article reviews
cyclin d2 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
cyclin d2 d52f9 ![]() Cyclin D2 D52f9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyclin+d2/Cyclin+D2+Rabbit+mAb/bio_rxiv__64898__2026__03__13__711608-274-125-129 Average 95 stars, based on 1 article reviews
cyclin d2 d52f9 - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
cyclin d2 ![]() Cyclin D2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyclin+d2/cyclin+D2+Antibody/pm41856058-70-31-34 Average 94 stars, based on 1 article reviews
cyclin d2 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
ccnd2 ![]() Ccnd2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyclin+d2/Cyclin+D2+Rabbit+pAb/pmc13050472-92-80-81 Average 94 stars, based on 1 article reviews
ccnd2 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Proteintech
ccnd2 ![]() Ccnd2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyclin+d2/Cyclin+D2+Antibody/pm41361309-154-84-85 Average 94 stars, based on 1 article reviews
ccnd2 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
Journal: Biomedical Reports
Article Title: Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis
doi: 10.3892/br.2026.2221
Figure Lengend Snippet: Effects of SNHG6 expression on LPS-stimulated chondrocytes. (A) The expression of SNHG6 in synovial fluid of normal individuals and patients with osteoarthritis was detected via RT-qPCR. (B) Following transfection of si-SNHG6 or OE-SNHG6 in LPS-induced chondrocytes, the expression of SNHG6 was detected via RT-qPCR. (C) The viability of LPS-induced chondrocytes that transfected with si-SNHG6 or OE-SNHG6 was measured by Cell Counting Kit-8 assay. (D and E) Cell frequency of LPS-induced chondrocytes was calculated via flow cytometric analysis. (F and G) The percentages of TUNEL-positive cells were assessed by TUNEL assay. Scale bar, 100 µm. (H and I) The apoptotic rate of LPS-induced chondrocytes was calculated via flow cytometric analysis. (J) The protein levels of Caspase-3, Caspase-9, Cyclin A1, Cyclin B1 and Cyclin D2 in LPS-induced chondrocytes that transfected with si-SNHG6 or OE-SNHG6 were determined via western blotting. (K) The levels of IL-6, TNF-α and IL-1β in LPS-induced chondrocytes that transfected with si-SNHG6 or OE-SNHG6 were determined via ELISA. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001. SNHG6, small nucleolar RNA host gene 6; LPS, lipopolysaccharide; RT-qPCR, reverse transcription-quantitative PCR; si-, small interfering; OE-, overexpression; ns, no significance; NC, negative control.
Article Snippet: Thereafter, the membrane was incubated overnight at 4 ̊C with primary antibodies directed against Caspase-3 (cat. no. ab32351; 1:5,000; Abcam), Caspase-9 (cat. no. ab32539; 1:5,000; Abcam), Cyclin A1 (cat. no. 13295-1-AP; 1:1,000; Proteintech Group, Inc.), Cyclin B1 (cat. no. 55004-1-AP; 1:2,000; Proteintech Group, Inc.),
Techniques: Expressing, Quantitative RT-PCR, Transfection, Cell Counting, Analysis, TUNEL Assay, Western Blot, Enzyme-linked Immunosorbent Assay, Reverse Transcription, Real-time Polymerase Chain Reaction, Over Expression, Negative Control
Journal: Biomedical Reports
Article Title: Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis
doi: 10.3892/br.2026.2221
Figure Lengend Snippet: Effects of miR-944 inhibition on LPS-stimulated chondrocytes. (A) Following transfection of miR-944 inhibitor or inhibitor NC in LPS-induced chondrocytes, the expression of miR-944 was detected via reverse transcription-quantitative PCR. (B) The viability of LPS-induced chondrocytes that transfected with miR-944 inhibitor or inhibitor NC was measured by Cell Counting Kit-8 assay. (C) Cell frequency of LPS-induced chondrocytes was calculated via flow cytometric analysis. (D) The percentages of TUNEL-positive cells were assessed by TUNEL assay. Scale bar, 100 µm. (E) The apoptotic rate of LPS-induced chondrocytes was calculated via flow cytometric analysis. (F) The protein levels of Caspase-3, Caspase-9, Cyclin A1, Cyclin B1 and Cyclin D2 in LPS-induced chondrocytes that transfected with miR-944 inhibitor or inhibitor NC were determined via western blotting. (G) The levels of IL-6, TNF-α and IL-1β in LPS-induced chondrocytes that transfected with miR-944 inhibitor or inhibitor NC were determined via ELISA. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001. miR, microRNA; LPS, lipopolysaccharide; NC, negative control.
Article Snippet: Thereafter, the membrane was incubated overnight at 4 ̊C with primary antibodies directed against Caspase-3 (cat. no. ab32351; 1:5,000; Abcam), Caspase-9 (cat. no. ab32539; 1:5,000; Abcam), Cyclin A1 (cat. no. 13295-1-AP; 1:1,000; Proteintech Group, Inc.), Cyclin B1 (cat. no. 55004-1-AP; 1:2,000; Proteintech Group, Inc.),
Techniques: Inhibition, Transfection, Expressing, Reverse Transcription, Real-time Polymerase Chain Reaction, Cell Counting, Analysis, TUNEL Assay, Western Blot, Enzyme-linked Immunosorbent Assay, Negative Control
Journal: Biomedical Reports
Article Title: Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis
doi: 10.3892/br.2026.2221
Figure Lengend Snippet: miR-944 interacts with PGAP1 to modulate proliferation, apoptosis and inflammation in LPS-stimulated chondrocytes. Following transfection of OE-PGAP1 or miR-944 mimics, (A) the viability of LPS-induced chondrocytes was measured by Cell Counting Kit-8 assay. (B) Cell frequency of LPS-induced chondrocytes was calculated via flow cytometric analysis. (C) The apoptotic rate of LPS-induced chondrocytes was calculated via flow cytometric analysis. (D and E) The percentages of TUNEL-positive cells were assessed by TUNEL assay. Scale bar, 100 µm. (F) The protein levels of Caspase-3, Caspase-9, Cyclin A1, Cyclin B1 and Cyclin D2 in LPS-induced chondrocytes were determined via western blotting. (G) The levels of IL-6, TNF-α and IL-1β in LPS-induced chondrocytes were determined via ELISA. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001. miR, microRNA; PGAP1, post-GPI attachment to protein 1; LPS, lipopolysaccharide; OE-, overexpression; NC, negative control; ns, no significance.
Article Snippet: Thereafter, the membrane was incubated overnight at 4 ̊C with primary antibodies directed against Caspase-3 (cat. no. ab32351; 1:5,000; Abcam), Caspase-9 (cat. no. ab32539; 1:5,000; Abcam), Cyclin A1 (cat. no. 13295-1-AP; 1:1,000; Proteintech Group, Inc.), Cyclin B1 (cat. no. 55004-1-AP; 1:2,000; Proteintech Group, Inc.),
Techniques: Transfection, Cell Counting, Analysis, TUNEL Assay, Western Blot, Enzyme-linked Immunosorbent Assay, Over Expression, Negative Control
Journal: International Journal of Biological Sciences
Article Title: Orphan Nuclear Receptor NR4A1 Promotes Proliferation and Osteogenic Differentiation of Valvular Interstitial Cells through Activation of CCND2
doi: 10.7150/ijbs.122863
Figure Lengend Snippet: CCND2, a target gene regulated by NR4A1, is capable of promoting the osteogenic differentiation of VICs. (A) Venn diagram illustrating the overlap between differentially expressed genes and genes associated with cell cycle regulation. (B) Scatter plot showing the correlation between NR4A1 and CCND2 expression levels in single cells. (C) Violin plot illustrating CCND2 expression levels in calcified valves versus normal valves. (D-E) In the differential valve tissues, the levels of CCND2, as well as the calcification markers ALP and RUNX2, were assessed and quantified by WB analysis (n = 10, each group). (F) Chromatin immunoprecipitation coupled with quantitative PCR (ChIP-qPCR) assay showing the enrichment of the CCND2 promoter region by NR4A1 in VICs under CTR and OM conditions (n = 3, each group). (G) Schematic illustration of the CCND2 gene promoter region (2 kb upstream of the transcription start site, TSS). The locations of three putative NR4A1 binding sites (Binding site1, Binding site2, Binding site3), predicted by Jaspar, are indicated, along with their respective DNA sequences. P1, P2, and P3 represent different promoter fragment plasmids. (H) Luciferase reporter assay showing relative luciferase activity in VICs transfected with the empty vector control (PGL3-Basic, which serves as a negative control with no luciferase expression) or different truncated CCND2 promoter plasmids (PGL3-P1, PGL3-P2, PGL3-P3), either with empty vector (blue) or NR4A1-overexpressing vector (red) (n = 3, each group). (I-K) Ki-67 and EdU staining of VICs under osteogenic stimulation following CCND2 knockout. (L-O) WB experiments of CCND2, RUNX2, and ALP expression in VICs following CCND2 silencing (n = 3, each group). (P-T) Following the silencing of the CCND2 gene, representative images were obtained from Alizarin Red staining and ALP staining in VICs. (n = 3, each group). Scale bar: 50 μm. Data are means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001(ANOVA with Tukey's multiple comparisons test).
Article Snippet: The following are the sources of all antibodies and reagents used in this study: runt-related transcription factor 2 (RUNX2) (CST, 8486, dilution ratio of 1:1000 for WB), RUNX2 (Santa Cruz, sc-390715, dilution ratio of 1:100 for Immunofluorescence staining), alkaline phosphatase (ALP) (MAB29092, R&D, dilution ratio of 1:1000 for WB), GAPDH (Proteintech, 60004-1-Ig, dilution ratio of 1:10000 for WB), NR4A1(CST, 3960, dilution ratio of 1:1000 for WB, dilution ratio of 1:100 for Immunofluorescence staining and immunohistochemistry staining), NR4A1 (Proteintech, 12235-1-AP, ChIP),
Techniques: Expressing, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction, ChIP-qPCR, Binding Assay, Luciferase, Reporter Assay, Activity Assay, Transfection, Plasmid Preparation, Control, Negative Control, Staining, Knock-Out
Journal: International Journal of Biological Sciences
Article Title: Orphan Nuclear Receptor NR4A1 Promotes Proliferation and Osteogenic Differentiation of Valvular Interstitial Cells through Activation of CCND2
doi: 10.7150/ijbs.122863
Figure Lengend Snippet: Silencing of CCND2 mitigates the osteogenic differentiation phenotype induced by NR4A1 overexpression in VICs. (A-E) Knockdown of CCND2 was able to inhibit the elevation of the levels of calcification markers ALP and RUNX2 induced by overexpression of NR4A1, as demonstrated by WB (n = 3, each group). (F-H) Visual representations of Ki-67 and EdU staining in VICs when NR4A1 was overexpressed and CCND2 was silenced (n = 3, each group). (I-M) Determination of calcified nodules and ALP activity in valvular interstitial cells with CCND2 gene silencing and NR4A1 overexpression (n = 3, per group). (N-R) Western blot analysis of calcification markers ALP and RUNX2 in VICs with NR4A1 silencing and CCND2 overexpression. (S-U) Visual representations of Ki-67 and EdU staining in VICs with NR4A1 silencing and CCND2 overexpression. (V-Z) Determination of calcified nodules and ALP activity in valvular interstitial cells with NR4A1 silencing and CCND2 overexpression. (n = 3, per group). Scale bar: 50 μm. Data are means ± SD. One-way ANOVA (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)
Article Snippet: The following are the sources of all antibodies and reagents used in this study: runt-related transcription factor 2 (RUNX2) (CST, 8486, dilution ratio of 1:1000 for WB), RUNX2 (Santa Cruz, sc-390715, dilution ratio of 1:100 for Immunofluorescence staining), alkaline phosphatase (ALP) (MAB29092, R&D, dilution ratio of 1:1000 for WB), GAPDH (Proteintech, 60004-1-Ig, dilution ratio of 1:10000 for WB), NR4A1(CST, 3960, dilution ratio of 1:1000 for WB, dilution ratio of 1:100 for Immunofluorescence staining and immunohistochemistry staining), NR4A1 (Proteintech, 12235-1-AP, ChIP),
Techniques: Over Expression, Knockdown, Staining, Activity Assay, Western Blot